Macclesfield, United Kingdom

Peter Duncan Smith


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Peter Duncan Smith

Introduction

Peter Duncan Smith, an inventive mind based in Macclesfield, GB, has made significant strides in the realm of cancer treatment. His contributions to the field are encapsulated in his patented invention, showcasing his dedication to advancing medical science.

Latest Patents

Peter holds one patent for his work on 1,3,4-thiadiazole compounds and their use in treating cancer. This innovative compound demonstrates potential in the fight against cancer, marking a key development in pharmaceutical research.

Career Highlights

Throughout his career, Peter has been affiliated with leading companies such as AstraZeneca and Cancer Research Technology Limited. His work in these organizations has been pivotal in pushing the envelope of cancer research and therapeutic development.

Collaborations

Peter Duncan Smith has collaborated with notable colleagues, including David Robert Perkins and Maurice Raymond Verschoyle Finlay. These collaborations have fostered an environment of innovation, merging various expertise to tackle common challenges in cancer treatment.

Conclusion

In conclusion, Peter Duncan Smith exemplifies the spirit of innovation within the medical field. His patent on 1,3,4-thiadiazole compounds not only demonstrates his individual prowess but also his commitment to improving cancer therapies through collaboration and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…